A Prospective Real-world Study to Assess Safety, Tolerability, and Effectiveness of Imeglimin among People with Type 2 Diabetes Mellitus Who are Intolerant to Metformin (PRISM Study)

Prabhat Kumar Agrawal, Ruchika Garg, Bharat Saboo et al.|Journal of the Association of Physicians of India|2026

Cited by 1